Repository logo
 
Publication

Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013

2015-06-02Journal article Restricted access
Simple item page
dc.contributor.authorBröker, Michael
dc.contributor.authorEmonet, Stéphane
dc.contributor.authorFazio, Cecilia
dc.contributor.authorJacobsson, Susanne
dc.contributor.authorKoliou, Maria
dc.contributor.authorKuusi, Markku
dc.contributor.authorPace, David
dc.contributor.authorParagi, Metka
dc.contributor.authorPysik, Alexander
dc.contributor.authorSimões, Maria João
dc.contributor.authorSkoczynska, Anna
dc.contributor.authorStefanelli, Paola
dc.contributor.authorToropainen, Maija
dc.contributor.authorTaha, Muhamed Kheir
dc.contributor.authorTzanakaki, Georgina
dc.date.accessioned2016-02-29T13:00:53Z
dc.date.available2017-06-02T00:30:10Z
dc.date.issued2015-06-02
dc.description.abstractNeisseria meningitidis or meningococcus is divided into 12 distinct serogroups of which A, B, C, W, X, and Y are medically most important and cause health problems in different parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. Globally, serogoup A has been prevalent in the African “meningitis belt” whereas serogroup B and C have predominated in Europe. In a paper published earlier in this journal1, an increase in serogroup Y invasive meningococcal disease (IMD) in some European countries was reported based on the epidemiological data for 2010, 2011 and 2012. Here, we report additional data from 30 European countries indicating that high or increased serogroup Y disease levels have continued in 2013 in certain regions of Europe. In the Western and Central Europe, there were no major changes in the proportion of serogroup Y IMD cases in 2013 compared to 2012. In the Scandinavian countries, proportion of serogroup Y disease remained high, ranging from 26% to 51% in 2013. This was in contrast to Baltic, Eastern and most Southern European countries, where the proportion of serogroup Y IMD was low similarly to previous years. For the last 2 decades, the mean age of patients affected by serogroup Y was 41 y for 7 countries from which data was available and 50% of cases were in patients aged 45 to 88 y. The age distribution of serogroup Y was bimodal and did not change significantly despite the increase of the total number and the proportion of serogroup Y IMD in some European regions.pt_PT
dc.identifier.citationHum Vaccin Immunother. 2015;11(9):2281-6. doi: 10.1080/21645515.2015.1051276.pt_PT
dc.identifier.doi10.1080/21645515.2015.1051276pt_PT
dc.identifier.issn2164-5515
dc.identifier.urihttp://hdl.handle.net/10400.18/3522
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherTaylor and Francispt_PT
dc.relation.publisherversionhttp://www.tandfonline.com/doi/abs/10.1080/21645515.2015.1051276?journalCode=khvi20pt_PT
dc.subjectInvasive Meningococcal Diseasept_PT
dc.subjectIMDpt_PT
dc.subjectMenpt_PT
dc.subjectMeningococcalpt_PT
dc.subjectNeisseria meningitidispt_PT
dc.subjectEpidemiologypt_PT
dc.subjectInvasive Meningococcal Diseasept_PT
dc.subjectMeningococcal Serogroup Ypt_PT
dc.subjectEuropept_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.subjectDoença Meningocócicapt_PT
dc.titleMeningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage2286pt_PT
oaire.citation.startPage2281pt_PT
oaire.citation.titleHuman Vaccines and Immunotherapeuticspt_PT
oaire.citation.volume11(9)pt_PT
rcaap.rightsembargoedAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Meningo Y 2013.pdf
Size:
1.01 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DDI - Artigos em revistas internacionais